期刊文献+

ABCG2表达水平与乳腺癌术后蒽环类药物化疗疗效和耐药性的关系 被引量:5

Relationship between ABCG2 expression and chemotherapeutic efficacy and drug resistance of anthracyclines after breast cancer surgery
下载PDF
导出
摘要 目的 探讨三磷酸腺苷结合转运蛋白G超家族成员2(adenosine triphosphate-binding cassette superfamily G member 2,ABCG2)的m RNA和蛋白表达水平与乳腺癌患者化疗疗效和耐药性的关系。方法 选取确诊为乳腺癌的患者24例作为研究对象,所有患者均经手术治疗后辅以蒽环类药物化疗,根据WHO疗效评价标准评估患者化疗后效果和耐药性,根据化疗效果将患者分为有效组、稳定组及进展组;分别于化疗前后利用q PCR和ELISA法检测患者乳腺组织中ABCG2的m RNA和蛋白表达水平。结果 化疗后总有效率为41.67%,即仍有58.33%的患者出现耐药性;化疗后患者ABCG2 m RNA和蛋白表达水平均显著高于化疗前(P〈0.05);化疗有效组的患者ABCG2 m RNA和蛋白表达水平显著低于化疗稳定组及进展组的患者(P〈0.05);化疗稳定组患者ABCG2 m RNA和蛋白表达水平显著低于进展组(P〈0.05)。结论ABCG2的表达水平与乳腺癌患者化疗疗效和耐药性相关,ABCG2表达水平越高,促进药物排泄的能力越强,肿瘤细胞的耐药性越显著,化疗疗效越差。 Objective To investigate the relationship between adenosine triphosphate-binding cassette superfamily G member 2 (ABCG2) mRNA and protein expressions and chemotherapeutic efficacy and drug resistance in breast cancer patients. Methods 24 patients with breast cancer were selected as study subjects, all patients were treated with anthracycline chemotherapy after chemotherapy, according to WHO criteria, the patients were divided into effective group, stable group and advanced group according to chemotherapy effect. The levels of ABCG2 mRNA and protein in the breast tissue were detected by qPCR and ELISA before and after chemotherapy. Results After chemotherapy, the total effective rate was 41.67%, 58.33% of patients still developed drug resistance. The expressions of ABCG2 mRNA and protein in patients after chemotherapy were significantly higher than those before chemotherapy ( P〈0.05). The expressions o f ABCG2 mRNA and protein were significantly lower in the effective group than in the stable group and advanced group ( P 〈0.05). The expressions o f ABCG2 mRNA and protein in the stable group was significantly lower than that in the advanced group (P〈0.05). Conclusion The expression level o f ABCG2 was correlated with the chemotherapeutic efficacy and drug resistance of breast cancer patients. The higher the ABCG2 expression level, the stronger the ability of promoting the excretion of drugs, the more significant the drug resistance of tumor cells and the worsen the chemotherapy effect.
出处 《中国生化药物杂志》 CAS 2017年第1期274-276,279,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 永康市科技计划项目(201611)
关键词 ABCG2 乳腺癌 化疗疗效 耐药性 乳腺组织 ABCG2 breast cancer chemotherapy efficacy drug resistance breast tissue
  • 相关文献

参考文献7

二级参考文献79

  • 1张爱民,胡佑伦.胃癌耐药基因的表达及其在药物适配个体化治疗中的意义[J].中华实验外科杂志,2004,21(12):1485-1487. 被引量:10
  • 2Amalia Azzariti,Letizia Porcelli,Jian-Ming Xu,Grazia Maria Simone,Angelo Paradiso.Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib(Iressa^(TM))and to the antiangiogenic agent ZD6474:Cytotoxic and biomolecular effects[J].World Journal of Gastroenterology,2006,12(32):5140-5147. 被引量:1
  • 3杨兆禄,尹凤玲,路中,戚丽,邵学叶.乳腺癌术后分阶段放疗的临床观察[J].中华肿瘤防治杂志,2007,14(20):1571-1573. 被引量:2
  • 4Hu L,McArthur C,Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant[J]. Br J Cancer,2010,102(8):1276-1283.
  • 5Shi H, Lu D, Shu Y, et al. Expression of muhidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-Ⅱ and lung resistance protein in primary gastric cardiac adenocarcinoma[J]. Cancer Invest, 2008,26 (4) : 344-351.
  • 6Cusatis G,Sparreboom A. Pharmacogenomic importance of AB- CG2[J]. Pharmacogenomics, 2008,9 (8) .. 1005-1009.
  • 7Sun N, Sun X,Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 2010,65 (3) : 437-446.
  • 8Kiyotani K, Mushiroda T, Imamura CK, et al. Significant effect of polymorphisms in CYP2D6 and ABCG2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients[J]. J Clin Oncol,2010,28(8):1287-1293.
  • 9Hu M, To KK, Mak VW, et al. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid- lowering effects of statins[J]. Expert Opin Drug Metab Toxicol, 2011,7(1):49-62.
  • 10Bleau AM, Huse JT, Holland EC. The ABCG2 resistance network of glioblastoma[J]. Cell Cycle,2009,8(18) :2936-2944.

共引文献91

同被引文献50

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部